CA1206881A - Anti seborrhoeic composition - Google Patents
Anti seborrhoeic compositionInfo
- Publication number
- CA1206881A CA1206881A CA000411830A CA411830A CA1206881A CA 1206881 A CA1206881 A CA 1206881A CA 000411830 A CA000411830 A CA 000411830A CA 411830 A CA411830 A CA 411830A CA 1206881 A CA1206881 A CA 1206881A
- Authority
- CA
- Canada
- Prior art keywords
- weight
- preparation
- agent
- acid
- scalp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 26
- 210000004761 scalp Anatomy 0.000 claims abstract description 19
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims abstract description 18
- 208000008742 seborrheic dermatitis Diseases 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims abstract 9
- 229960005280 isotretinoin Drugs 0.000 claims abstract 9
- 206010039792 Seborrhoea Diseases 0.000 claims abstract 4
- 239000002453 shampoo Substances 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 27
- 230000000699 topical effect Effects 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 4
- 239000004615 ingredient Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 150000002148 esters Chemical class 0.000 abstract description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 13
- 229930002330 retinoic acid Natural products 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- 235000002639 sodium chloride Nutrition 0.000 description 10
- -1 alkali metal salts Chemical class 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000003599 detergent Substances 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229920000180 alkyd Polymers 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 235000017858 Laurus nobilis Nutrition 0.000 description 5
- 244000125380 Terminalia tomentosa Species 0.000 description 5
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 239000004088 foaming agent Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003209 petroleum derivative Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 239000011703 D-panthenol Substances 0.000 description 2
- 235000004866 D-panthenol Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960003949 dexpanthenol Drugs 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000168025 Cervus elaphus elaphus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000020071 rectified spirit Nutrition 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- HVFAVOFILADWEZ-UHFFFAOYSA-M sodium;2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCN(CCO)CC([O-])=O HVFAVOFILADWEZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Abstract A preparation for treating seborrhoea, seborrhoeic dermatitis and seborrhoeic eczema of the scalp containing as an active ingredient 13-cis Vitamin A acid, esters or pharmaceutically acceptable salts thereof to the scalp.
Description
~LZ~6~38~
The compound Swiss Vitamin A acid has been used topically or orally in selected areas of dermatology such as in the treatment of acne. See united Kingdom Patent No. 1,335,867; Peck et at., New Erg. J. Med. 300:329-333 (1959) and Gunny JIMMY. 240:610 (1978). Furthermore, 10 this compound has been used orally in the treatment and prophylaxis of carcinomas of the epithelial cells. Sworn et at. Federation Proceedings, 35, No. 6,1332 (1976). In addition, Swiss Vitamin A acid has been used orally and subcutaneously to suppress the secretion of the setaceous 15 glands. See Gums it 21., J. Invest, Dermatol. 74:392-7 tl980) and Strauss, Abstract No. 29, Into Dermatol. Swamp-slum Oct. 13-15, 1980, Berlin, Germany.
As seen from above, these publications demonstrate 20 that Swiss retinoic acid orally administered has been shown to he effective in the control of various Durham-to logical disorders such as acne, psoriasis and other no-fated disorders. However, many compounds, useful in the control of acne, psoriasis and related disorders, have I little, if any, effect on the control of Siberia, seborrhoeic dermatitis and seborrhoeic eczema, which cause dandruff, loss of hair, and other related disorders. It has long been desired to provide an agent effective in controlling, either through treating or through trophy-30 taxis, Siberia, seborrhoeic dermatitis and seborrhoeiceczema of the scalp.
In accordance with this invention, it has been disk covered that when an agent selected from the group consist 35 tying of Swiss Vitamin A acid, lower alkyd esters thereof :: ;
Gun/ 6 . g . 8 2 `_ : ' . :,_`~ ' .
:
0688~L
and pharmaceutically acceptable salts, as well as mixtures thereon, are applied to the scalp control of Siberia, seborrhoeic dermatitis and seborrhoeic eczema is achieved.
In carrying out this invention, any pharmaceutically accept table salt of Swiss Vitamin A acid can be utilize. Among the preferred salts are included the alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and ammonium salts. The term "lower alkyd esters" as used in the specification designates any conventional lower alkyd ester where the lower alkyd group contains from 1 to 7 carbon atoms. Among the preferred lower alkyd esters are the methyl, ethyl, n-propyl, isopropyl, n-butyl, and isobutyl esters.
In applying the agent of this invention, any convent tonal inert carrier for topical application to the scalp can be utilized in formulating the compositions containing these agents. The pharmaceutical preparation utilized in accordance with the present invention can be manufactured 20 by mixing the aforementioned agents with one or more pear-mystical acceptable carriers suitable for topical ad-ministration by conventional methods.
In accordance with this invention, it has been found I that the aforementioned agents are effective against Siberia, seborrhoeic dermatitis and seborrhoeic eczema of the scalp particularly dandruff and hair loss. Among the other disorders associated with Siberia of the scalp are included: Siberia wapitis; dermatitis Siberia-hoe; Siberia in M. Parkinson and Parkinsonism.
For topical administration to the scalp, the agent scan be conventionally prepared as ointments, tinctures, creams, gels, solutions, lotions, sprays, suspensions, shampoos, hair soaps, perfumes and the like. In fact, any conventional composition utilized for application to the scalp can be utilized in accordance with this invention.
Among the preferred methods of applying the composition 36~8~L
containing the agents of this invention is in the form ox shampoos, solutions and perfumes. The pharmaceutical pro-parathion for topical administration to the scalp can be prepared by mixing the aforementioned active ingredient with non-toxic, therapeutically inert, solid or liquid carriers customarily used in such preparations. Generally, these preparations should contain from about 0.001% to about 5% by weight, based upon the total weight of the combo-session of the active ingredient with 0.01 to lye by weight 10 being preferred and 0.1% to 0.4% by weight being especially preferred. Generally the concentration of the active inure-dint in shampoos is from about 0.2 to 2% by weight based upon the total weight of the shampoo and in lotions from 0.01 to 0.5 by weight. Generally, it is preferred to apply these preparations once or twice daily to the scalp. These preparations can be applied according to the need of the patient.
In carrying out this invention, the active inure-20 dint can be applied in a solution of an alcohol such as ethyl alcohol which contains from about 0.001% to about 5% by weight of the active ingredient. Generally, it is preferred to use an alcohol solution containing from about 0.01% to about 0.5% by weight, of the active ingredient in the alcohol.
In preparing the topical preparations described above additives such as preservatives, thickeners, perfumes and the like conventional in the art of pharmaceutical compounding of topical preparation can be used. In add-lion, conventional antioxidant or mixtures of convent tonal antioxidant can be incorporated into the topical preparations containing the aforementioned active agent Among the conventional antioxidant which can be utilized in these preparations are included ~-methyl-a-tocopherol-amine, tocopherols, butylated hydroxyanisole, bu-tylated hydroxytoluene, ethoxyquin and the like. Cream-base pear-mystical formulations containing the active agent, used .... .
, ZV688~
in accordance with this invention, are composed of aqueous emulsions containing a fatty acid alcohol, semi-solid petroleum hydrocarbon, lo ethyleneglycol and an emulsi-lying agent.
ointment formulations containing the active agent in accordance with this invention comprise admixtures of a semi-solid petroleum hydrocarbon with a solvent dispel-soon of the active material. Cream compositions containing the active ingredient for use in this invention preferably comprise emulsions formed from a water phase of a hummock-lent, a viscosity stabilizer and water, an oil phase of fatty acid alcohol, a semi-solid petroleum hydrocarbon an an emulsifying agent and a phase containing the active 15 agent dispersed in an aqueous stabilizer-buffer solution Stabilizers may be added to the topical preparation. Any conventional stabilizer can be utilized in accordance with this invention. In the oil phase, fatty acid alcohol come pennants function as a stabilizer. These fatty acid alcohol 20 components are derived from the reduction of a long-chain saturated fatty acid from about 14 carbon atoms. Also, conventional perfumes and lotions goner fly utilized in topical preparation for the hair can be utilized in accord dance with this invention. Furthermore, if desired, convent 25 tonal emulsifying agents can be utilized in the topical preparations of this invention.
In accordance with a preferred embodiment of this invention, the Swiss retinoic acid is incorporated into 30 an aqueous shampoo. This shampoo provides a means or treating the scalp and hair for controlling Siberia, seborrhoeic dermatitis and seborrhoeic eczema of the scalp.
In accordance with this preferred embodiment, the concern-traction of the aforementioned agent in the shampoo is from 35 about 0.2 to 2.0%, by weight of the shampoo composition, with amounts of from about 0.5 to 1% by weight being pro-furred. Generally these shampoos can be applied to control said disorders of the scalp according to the needs of the ~206i38~
patient. In general, these shampoos are applied once or twice daily.
The agent of this invention can be incorporated in-to any conventional aqueous shampoo composition. Generally, these shampoos contain water in an amount of from about 40% to 92% by weight. These shampoos also contain surface active agents or detergents in an amulet of from about 5% to 20% by weight of the shampoo composition, with amounts 10 of about lo to 15% by weight being generally preferred. Any conventional surface active agent or detergent for pro-paring shampoo composition can be utilized in accordance with this invention. These detergents or surfactants are preferably either amphoteric or anionic surface active 15 agents. Among the preferred surface active agents or deter-gents are the alkali metal salts of laurel ether sulfates, alkali metals salts of laurel sulfates, as well as the alkali metal salt or ammonium salts of N-beta-hydroxy-ethyl-N-carboxymethyl fatty acid aminoethylamine, fatty 20 alkyldicarboxylic derivatives of imidazolines, alkyd beta-aminoproprionates, sodium polyhydroxy monoether sulk fates, coequal sarcosine, die-thanol/triethanol ammonium laurel sulfate, triethanol amine laurel ether sulfate. Des-creations of various surface active agents and detergents 25 employable in the present shampoos are found in the text Non ionic Surfactants, edited by My Schick and published in l9~7 by Marcel Decker, Inc., and Surface Active Agents and Detergents, Vol. II, by ARM. Schwartz, JAW. Perry and J. Bench, published in 1958 by Intrusions Publishers.
30 Furthermore, shampoos in general contain foaming agents in am amount of from about 2% to 15% by weight of the shampoo with mounts of from 5 to 15% being especially preferred.
Any conventional foaming agent which is generally utilized in shampoos can be utilized in preparing the shampoo come 35 position of this invention. Among the preferred foaming agents are included the coconut fatty acid ethanolamides such as Laurie acid moo or diethanol aside, oleic acid moo or diethanol asides.
6~38~
\
In addition Jo containing the surfactants or deter-gents and foaming agents, the aqueous shampoo composition of this invention may contain, if desired, various other optional adjutants which are generally employed in forum-feting aqueous shampoo compositions. Among these optionaladjuvants are included perfumes and fragrances. Any con-ventional material utilized as perfumes may be incorpo-rated into the shampoo composition of this invention.
Other adjutants which can be incorporated into the aqueous 10 shampoo compositions of this invention include viscosity control agents such as propylene glycol, alcohols such as ethyl alcohols, etc.; conditioning agents such as pro-loin, Panty, D-panthenol, etc.; soaps such as potassium laureate, sodium Stewart, stabilizers and buffers such as 15 sodium phosphate, sodium biphosphate, etc.; pH-adjusters such as citric acids, etc.; pacifiers, etc. Generally, the shampoo composition of this invention contains a pi of from 5.5 to 8.5, with 6.0 to 7.5 being especially pro-furred.
I
The invention is further illustrated by the following examples. In the examples, all percents are percents by weight.
Example 1 Pyrolyzed hair shampoo Wyeth Swiss Vitamin A acid The following composition was packaged in an alum minim tube with interior protective lacquering:
1000 g contain:
Nope owe 3~,35 g an hydrous citric Acadia g Sactol 2 OX 28 (1)300.00 g Steinapon AM 2 L 70.00 g Panty 1.00 g D-Panthenol 4,00 g Swiss Vitamin A Acadia g Euperlan PI 771 50.00 g Sactilan LDC ( ) 20.00 g Perfume PLY 3072 4.00 g Demineralized whetter g I
( ) Laurel ether sulfate, No salt
The compound Swiss Vitamin A acid has been used topically or orally in selected areas of dermatology such as in the treatment of acne. See united Kingdom Patent No. 1,335,867; Peck et at., New Erg. J. Med. 300:329-333 (1959) and Gunny JIMMY. 240:610 (1978). Furthermore, 10 this compound has been used orally in the treatment and prophylaxis of carcinomas of the epithelial cells. Sworn et at. Federation Proceedings, 35, No. 6,1332 (1976). In addition, Swiss Vitamin A acid has been used orally and subcutaneously to suppress the secretion of the setaceous 15 glands. See Gums it 21., J. Invest, Dermatol. 74:392-7 tl980) and Strauss, Abstract No. 29, Into Dermatol. Swamp-slum Oct. 13-15, 1980, Berlin, Germany.
As seen from above, these publications demonstrate 20 that Swiss retinoic acid orally administered has been shown to he effective in the control of various Durham-to logical disorders such as acne, psoriasis and other no-fated disorders. However, many compounds, useful in the control of acne, psoriasis and related disorders, have I little, if any, effect on the control of Siberia, seborrhoeic dermatitis and seborrhoeic eczema, which cause dandruff, loss of hair, and other related disorders. It has long been desired to provide an agent effective in controlling, either through treating or through trophy-30 taxis, Siberia, seborrhoeic dermatitis and seborrhoeiceczema of the scalp.
In accordance with this invention, it has been disk covered that when an agent selected from the group consist 35 tying of Swiss Vitamin A acid, lower alkyd esters thereof :: ;
Gun/ 6 . g . 8 2 `_ : ' . :,_`~ ' .
:
0688~L
and pharmaceutically acceptable salts, as well as mixtures thereon, are applied to the scalp control of Siberia, seborrhoeic dermatitis and seborrhoeic eczema is achieved.
In carrying out this invention, any pharmaceutically accept table salt of Swiss Vitamin A acid can be utilize. Among the preferred salts are included the alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and ammonium salts. The term "lower alkyd esters" as used in the specification designates any conventional lower alkyd ester where the lower alkyd group contains from 1 to 7 carbon atoms. Among the preferred lower alkyd esters are the methyl, ethyl, n-propyl, isopropyl, n-butyl, and isobutyl esters.
In applying the agent of this invention, any convent tonal inert carrier for topical application to the scalp can be utilized in formulating the compositions containing these agents. The pharmaceutical preparation utilized in accordance with the present invention can be manufactured 20 by mixing the aforementioned agents with one or more pear-mystical acceptable carriers suitable for topical ad-ministration by conventional methods.
In accordance with this invention, it has been found I that the aforementioned agents are effective against Siberia, seborrhoeic dermatitis and seborrhoeic eczema of the scalp particularly dandruff and hair loss. Among the other disorders associated with Siberia of the scalp are included: Siberia wapitis; dermatitis Siberia-hoe; Siberia in M. Parkinson and Parkinsonism.
For topical administration to the scalp, the agent scan be conventionally prepared as ointments, tinctures, creams, gels, solutions, lotions, sprays, suspensions, shampoos, hair soaps, perfumes and the like. In fact, any conventional composition utilized for application to the scalp can be utilized in accordance with this invention.
Among the preferred methods of applying the composition 36~8~L
containing the agents of this invention is in the form ox shampoos, solutions and perfumes. The pharmaceutical pro-parathion for topical administration to the scalp can be prepared by mixing the aforementioned active ingredient with non-toxic, therapeutically inert, solid or liquid carriers customarily used in such preparations. Generally, these preparations should contain from about 0.001% to about 5% by weight, based upon the total weight of the combo-session of the active ingredient with 0.01 to lye by weight 10 being preferred and 0.1% to 0.4% by weight being especially preferred. Generally the concentration of the active inure-dint in shampoos is from about 0.2 to 2% by weight based upon the total weight of the shampoo and in lotions from 0.01 to 0.5 by weight. Generally, it is preferred to apply these preparations once or twice daily to the scalp. These preparations can be applied according to the need of the patient.
In carrying out this invention, the active inure-20 dint can be applied in a solution of an alcohol such as ethyl alcohol which contains from about 0.001% to about 5% by weight of the active ingredient. Generally, it is preferred to use an alcohol solution containing from about 0.01% to about 0.5% by weight, of the active ingredient in the alcohol.
In preparing the topical preparations described above additives such as preservatives, thickeners, perfumes and the like conventional in the art of pharmaceutical compounding of topical preparation can be used. In add-lion, conventional antioxidant or mixtures of convent tonal antioxidant can be incorporated into the topical preparations containing the aforementioned active agent Among the conventional antioxidant which can be utilized in these preparations are included ~-methyl-a-tocopherol-amine, tocopherols, butylated hydroxyanisole, bu-tylated hydroxytoluene, ethoxyquin and the like. Cream-base pear-mystical formulations containing the active agent, used .... .
, ZV688~
in accordance with this invention, are composed of aqueous emulsions containing a fatty acid alcohol, semi-solid petroleum hydrocarbon, lo ethyleneglycol and an emulsi-lying agent.
ointment formulations containing the active agent in accordance with this invention comprise admixtures of a semi-solid petroleum hydrocarbon with a solvent dispel-soon of the active material. Cream compositions containing the active ingredient for use in this invention preferably comprise emulsions formed from a water phase of a hummock-lent, a viscosity stabilizer and water, an oil phase of fatty acid alcohol, a semi-solid petroleum hydrocarbon an an emulsifying agent and a phase containing the active 15 agent dispersed in an aqueous stabilizer-buffer solution Stabilizers may be added to the topical preparation. Any conventional stabilizer can be utilized in accordance with this invention. In the oil phase, fatty acid alcohol come pennants function as a stabilizer. These fatty acid alcohol 20 components are derived from the reduction of a long-chain saturated fatty acid from about 14 carbon atoms. Also, conventional perfumes and lotions goner fly utilized in topical preparation for the hair can be utilized in accord dance with this invention. Furthermore, if desired, convent 25 tonal emulsifying agents can be utilized in the topical preparations of this invention.
In accordance with a preferred embodiment of this invention, the Swiss retinoic acid is incorporated into 30 an aqueous shampoo. This shampoo provides a means or treating the scalp and hair for controlling Siberia, seborrhoeic dermatitis and seborrhoeic eczema of the scalp.
In accordance with this preferred embodiment, the concern-traction of the aforementioned agent in the shampoo is from 35 about 0.2 to 2.0%, by weight of the shampoo composition, with amounts of from about 0.5 to 1% by weight being pro-furred. Generally these shampoos can be applied to control said disorders of the scalp according to the needs of the ~206i38~
patient. In general, these shampoos are applied once or twice daily.
The agent of this invention can be incorporated in-to any conventional aqueous shampoo composition. Generally, these shampoos contain water in an amount of from about 40% to 92% by weight. These shampoos also contain surface active agents or detergents in an amulet of from about 5% to 20% by weight of the shampoo composition, with amounts 10 of about lo to 15% by weight being generally preferred. Any conventional surface active agent or detergent for pro-paring shampoo composition can be utilized in accordance with this invention. These detergents or surfactants are preferably either amphoteric or anionic surface active 15 agents. Among the preferred surface active agents or deter-gents are the alkali metal salts of laurel ether sulfates, alkali metals salts of laurel sulfates, as well as the alkali metal salt or ammonium salts of N-beta-hydroxy-ethyl-N-carboxymethyl fatty acid aminoethylamine, fatty 20 alkyldicarboxylic derivatives of imidazolines, alkyd beta-aminoproprionates, sodium polyhydroxy monoether sulk fates, coequal sarcosine, die-thanol/triethanol ammonium laurel sulfate, triethanol amine laurel ether sulfate. Des-creations of various surface active agents and detergents 25 employable in the present shampoos are found in the text Non ionic Surfactants, edited by My Schick and published in l9~7 by Marcel Decker, Inc., and Surface Active Agents and Detergents, Vol. II, by ARM. Schwartz, JAW. Perry and J. Bench, published in 1958 by Intrusions Publishers.
30 Furthermore, shampoos in general contain foaming agents in am amount of from about 2% to 15% by weight of the shampoo with mounts of from 5 to 15% being especially preferred.
Any conventional foaming agent which is generally utilized in shampoos can be utilized in preparing the shampoo come 35 position of this invention. Among the preferred foaming agents are included the coconut fatty acid ethanolamides such as Laurie acid moo or diethanol aside, oleic acid moo or diethanol asides.
6~38~
\
In addition Jo containing the surfactants or deter-gents and foaming agents, the aqueous shampoo composition of this invention may contain, if desired, various other optional adjutants which are generally employed in forum-feting aqueous shampoo compositions. Among these optionaladjuvants are included perfumes and fragrances. Any con-ventional material utilized as perfumes may be incorpo-rated into the shampoo composition of this invention.
Other adjutants which can be incorporated into the aqueous 10 shampoo compositions of this invention include viscosity control agents such as propylene glycol, alcohols such as ethyl alcohols, etc.; conditioning agents such as pro-loin, Panty, D-panthenol, etc.; soaps such as potassium laureate, sodium Stewart, stabilizers and buffers such as 15 sodium phosphate, sodium biphosphate, etc.; pH-adjusters such as citric acids, etc.; pacifiers, etc. Generally, the shampoo composition of this invention contains a pi of from 5.5 to 8.5, with 6.0 to 7.5 being especially pro-furred.
I
The invention is further illustrated by the following examples. In the examples, all percents are percents by weight.
Example 1 Pyrolyzed hair shampoo Wyeth Swiss Vitamin A acid The following composition was packaged in an alum minim tube with interior protective lacquering:
1000 g contain:
Nope owe 3~,35 g an hydrous citric Acadia g Sactol 2 OX 28 (1)300.00 g Steinapon AM 2 L 70.00 g Panty 1.00 g D-Panthenol 4,00 g Swiss Vitamin A Acadia g Euperlan PI 771 50.00 g Sactilan LDC ( ) 20.00 g Perfume PLY 3072 4.00 g Demineralized whetter g I
( ) Laurel ether sulfate, No salt
(2) N-beta-hydroxyethyl-N-carboxymethyl fatty acid amidoethylamine, No salt I Pyrolyzing concentrate, mixture of deterrents and 26 pyrolyzing agents; manufacturer: Henkel & Co., Dusseldorf, Germany (4) Coconut fatty acid diethanol aside ( ) ~-panthenol ethyl ether.
D `:!
. ,, ``
~206~
Example 2 Hair lotion with 0 05/~ Swiss Vitamin A acid The following aqueous alcoholic solution was packaged in black lacquered plastic bottles:
1000 ml contains:
Rectified ethyl alcohol 94% 600.00 g 10 Glycofurol 75 ( ) 2.00 g Swiss Vitamin A acid 0.50 g Distilled water ad 1000.00 ml Example 3 Active lotion with 0.10% Swiss Vitamin A acid An aqueous isopropanol solution containing the folio-wing composition was packaged in-black-dyed plastic bottles:
I
1000 ml contained:
Isopropanol 550.00 g Glycofurol 75 (1) 20.00 g Swiss Vitamin A acid 1.00 g 25 distilled water ad 1000.00 ml Mixture of equal parts off tetrahyd.rofurfuryloxy-ethanol and 2-(2-tetrahydrofurfuryloxy~-ethoxy-ethanol.
Example 4 Hair lotion with 0.02% Swiss Vitamin A acid An aqueous alcoholic solution containing the folio-wing composition was packaged in black lacquered plastic mottles:
61~
g 1000 ml contain:
Rectified alcohol 94%600.00 g Glycofurol 75 2. 00 g Swiss Vitamin A acid 0.20 g Disk tilled water ad 1000. 00 ml :
D `:!
. ,, ``
~206~
Example 2 Hair lotion with 0 05/~ Swiss Vitamin A acid The following aqueous alcoholic solution was packaged in black lacquered plastic bottles:
1000 ml contains:
Rectified ethyl alcohol 94% 600.00 g 10 Glycofurol 75 ( ) 2.00 g Swiss Vitamin A acid 0.50 g Distilled water ad 1000.00 ml Example 3 Active lotion with 0.10% Swiss Vitamin A acid An aqueous isopropanol solution containing the folio-wing composition was packaged in-black-dyed plastic bottles:
I
1000 ml contained:
Isopropanol 550.00 g Glycofurol 75 (1) 20.00 g Swiss Vitamin A acid 1.00 g 25 distilled water ad 1000.00 ml Mixture of equal parts off tetrahyd.rofurfuryloxy-ethanol and 2-(2-tetrahydrofurfuryloxy~-ethoxy-ethanol.
Example 4 Hair lotion with 0.02% Swiss Vitamin A acid An aqueous alcoholic solution containing the folio-wing composition was packaged in black lacquered plastic mottles:
61~
g 1000 ml contain:
Rectified alcohol 94%600.00 g Glycofurol 75 2. 00 g Swiss Vitamin A acid 0.20 g Disk tilled water ad 1000. 00 ml :
Claims (16)
1. A topical preparation for controlling disorders due to seborrhoea, seborrhoeic dermatitis or seborrhoeic eczema of the scalp containing an effective amount of an agent selected from the group consisting of 13-cis vitamin A acid, lower alkyl esters, salts and mixture thereof, together with a conventional inert carrier for topical application to the scalp.
2. A preparation of claim 1 wherein said agent is 13-cis vitamin A acid.
3. A preparation of claim 1 which is in the form of a shampoo.
4. A preparation of claim 1 which is in the form of a lotion.
5. A preparation of claim 1 wherein the effective amount of said agent from about .001 to 5% by weight, based upon the weight of the preparation.
6. A preparation of claim 5 wherein said preparation contains .01% to 2% by weight of said agent.
7. A preparation of claim 3 comprising from about:
a) .2% to 2% by weight of 13 cis Vitamin A acid, lower alkyl esters, salts and mixtures thereof:
b) 5% to 20% by weight of a surface active agent;
c) 2% to 15% by weight of a forming agent; and d) 40% to 92% by weight of water.
a) .2% to 2% by weight of 13 cis Vitamin A acid, lower alkyl esters, salts and mixtures thereof:
b) 5% to 20% by weight of a surface active agent;
c) 2% to 15% by weight of a forming agent; and d) 40% to 92% by weight of water.
8. A preparation of claim 7 wherein agent is 13-cis Vitamin A acid.
9. A preparation of claim 8 wherein said acid is pre-sent in an amount of from about 0.5 to 1% by weight of said preparation.
10. A method of preparing a topical preparation for controlling disorders due to seborrhoea, seborrhoeic derma-titis or seborrhoeic eczema of the scalp comprising mixing an effective amount of an agent selected from the group consisting of 13-cis vitamin A acid, lower alkyl esters, salts and mixture thereof, with a conventional inert carrier for topical application to the scalp.
11. A method as in claim 10 wherein said agent is 13-cis vitamin A acid.
12. A method as in claim 10 which is in the form of a shampoo.
13. A method as in claim 10 which is in the form of a lotion.
14. A method as in claim 10 wherein the effective amount of said agent from about .001 to 5% by weight, based upon the weight of the preparation.
15. A method as in claim 10 for preparing a shampoo for controlling disorders due to seborrhoea, seborrhoeic derma-titis or seborrhoeic eczema of the scalp comprising mixing the following ingredients:
a) .2% to 2% by weight of 13-cis Vitamin A acid, lower alkyl esters, salts and mixtures thereof;
b) 5% to 20% by weight of a surface active agent;
c) 2% to 15% by weight of a forming agent; and d) 40% to 92% by weight of water.
a) .2% to 2% by weight of 13-cis Vitamin A acid, lower alkyl esters, salts and mixtures thereof;
b) 5% to 20% by weight of a surface active agent;
c) 2% to 15% by weight of a forming agent; and d) 40% to 92% by weight of water.
16. A method as in claim 15 wherein the agent is 13-cis Vitamin A acid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30805881A | 1981-10-02 | 1981-10-02 | |
US308,058 | 1981-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1206881A true CA1206881A (en) | 1986-07-02 |
Family
ID=23192362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000411830A Expired CA1206881A (en) | 1981-10-02 | 1982-09-21 | Anti seborrhoeic composition |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1206881A (en) |
-
1982
- 1982-09-21 CA CA000411830A patent/CA1206881A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5001156A (en) | Lipophilic quaternary ammonium salicylates, their use in cosmetics and in dermopharmacy | |
DE69101922T2 (en) | USE OF PYRIMIDINE-3-OXYD DERIVATIVES FOR THE PREVENTION OF HAIR LOSS AND THEIR USE IN TOPICAL COMPOSITIONS. | |
KR100191818B1 (en) | Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use | |
IE34412B1 (en) | Liquid shampoos | |
EP1166766B1 (en) | External preparation compositions | |
US5527492A (en) | Cosmetic and detergent product comprising hinokitiol and a mixture of anionic surfactant and amphoteric surfactant | |
JPH04173723A (en) | Medicated cosmetic | |
JPS6220167B2 (en) | ||
JPS6341364B2 (en) | ||
GB1514287A (en) | Derivatives of alkanediols | |
JP2006500396A (en) | Branched alcohol personal care composition | |
CA1126157A (en) | Cosmetic compositions containing tioethers for treatment of greasy hair and skin | |
US5230890A (en) | Urethane derivatives from amino acids, a process for their preparation and cosmetic or pharmaceutical compositions for use in the treatment of dry skin | |
CA1206881A (en) | Anti seborrhoeic composition | |
EP0290020B1 (en) | Quaternary ammonium retinoates, and their cosmetic and dermopharmaceutical use | |
CA1134824A (en) | Cosmetic composition for the treatment of seborrhea, novel composition and preparation process | |
JPH0574566B2 (en) | ||
IE54244B1 (en) | Cosmetic hair-care and skin-care compositions | |
JPH11116446A (en) | External preparation for head | |
US3109777A (en) | Compositions for treatment of the hair | |
US6291532B1 (en) | Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss | |
EP0347328B1 (en) | Composition containing an amphoteric surfactant and a pyrimidine derivative to induce and stimulate the hair growth and/or to reduce hair loss | |
JPH0848625A (en) | Sebum secretion suppressive agent | |
WO1991011983A1 (en) | Novel use of alkanamidocarboxybetaine | |
GB2208268A (en) | Hydroperoxide for use in the treatment of acne and seborrhoea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |